Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00231010 · ClinicalTrials.gov registry record
Molecular Genetics of Retinal Degenerations
A clinical trial of Retinitis Pigmentosa and Retinal Degeneration, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 3,549
- Enrollment target
- 6
- Study locations
NCT00231010 is a study of Retinitis Pigmentosa and Retinal Degeneration that has completed, run by National Eye Institute (NEI). The registered enrollment target is 3,549 participants, above the 165-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (2051% higher). The trial reports 6 study locations across 4 states.
The verdict
NCT00231010, a study of Retinitis Pigmentosa and Retinal Degeneration, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 3,549 participants
- Enrollment target
- 6
- Study locations
Study Summary
This multinational study will investigate the inheritance of genetic retinal degeneration in families of different nationalities and ethnic backgrounds in order to identify the genes that, when altered, cause retinal degeneration. The retina is a light-sensitive membrane lining the back part of the eye. It relays vision signals to the brain, which the brain interprets into sight. When the retina degenerates, vision is altered and possibly lost. The findings of this study should help improve diagnosis and methods of treatment for these disorders. Participating institutions include: the National Institutes for Health in Bethesda, Maryland; the University of Miami in Florida; the Casey Eye Institute in Portland, Oregon; the Byrd Health Sciences Center in Morgantown, West Virginia; the University of Texas Southwestern Medical School in Dallas, Texas; the University of Tennessee Health Sciences Center in Memphis; the Prasad Eye Institute in Hyderabad, India; National Center of Excellence in Molecular Biology in Lahore, Pakistan; and the Jules Gonin Hospital in Lausanne, Switzerland. Patients with retinitis pigmentosa and closely related diseases such as Usher syndrome, snowflake vitreoretinal dystrophy and Bietti crystalline dystrophy may be eligible for this study. Participants undergo the following tests and procedures: * Medical and surgical history, including family history of vision problems. * Examination to clarify the type of retinal degeneration. * Eye examination, including tests of color vision, field of vision and ability to see in the dark * Electroretinogram to test the function of visual cells. For this test, the patient sits in a dark room for 30 minutes with his or her eyes patched. Then, a small electrode (silver disk) is taped to the forehead and the eye patches are removed. The surface the eyes is numbed with eye drops, and contact lenses are placed on the eyes. The patient looks inside a large dark globe that emits a series of light flashes. Then a
Conditions Studied
Study Locations (6)
Other
- Sun Yat-Sen University - Guangzhou
- Aravind Eye Hospital - Maduri
- University of Punjab - Lahore
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Massachusetts
- Harvard Medical School - Boston
Ohio
- Cleveland Clinic Foundation Childrens Hospital - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,549 participants |
| Start Date | 2005-09-26 |
| Est. Completion | 2016-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00231010
The ClinicalTrials.gov registry entry for NCT00231010 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,549 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 165-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (2051% higher). The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 0 interventions.
NCT00231010 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Other, Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00231010 about?
NCT00231010 is a clinical study titled "Molecular Genetics of Retinal Degenerations". This multinational study will investigate the inheritance of genetic retinal degeneration in families of different nationalities and ethnic backgrounds in order to identify the genes that, when altered, cause retinal degeneration. The retina is a light-sensitive membrane lining the back part of the ...
What is the current status of trial NCT00231010?
This trial is currently completed. The enrollment target is 3,549 participants. The study started on 2005-09-26. Estimated completion is 2016-06-23.
What conditions does trial NCT00231010 study?
This clinical trial studies the following conditions: Retinitis Pigmentosa, Retinal Degeneration.
Who is sponsoring clinical trial NCT00231010?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00231010 being conducted?
This trial has 6 study locations across Maryland, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinitis Pigmentosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promising ROd-cone DYstrophy Gene therapY
RECRUITING · Phase 1
-
High Resolution Retinal Imaging
RECRUITING
-
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
RECRUITING · Phase 2
-
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
RECRUITING
-
Retinal Imaging in Patients With Inherited Retinal Degenerations
RECRUITING
-
Cell Collection to Study Eye Diseases
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.